Interactions médicamenteuses
Amitriptyline + Selpercatinib
Gravité: Majeure
Amitriptyline and Selpercatinib: major interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Both drugs can prolong the QT interval, so combining them may increase the risk of ventricular arrhythmias including Torsades de Pointes. The risk is greater with electrolyte disturbances or underlying heart disease.
Ce que signifie cette interaction, en termes simples
Amitriptyline and Selpercatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Amitriptyline belongs to Central Nervous System; Selpercatinib belongs to Oncology.
Pourquoi elle survient
Additive QTc prolongation through pharmacodynamic effects on cardiac repolarization.
Conduite à tenir
Monitor ECG and electrolytes at baseline and periodically, correcting potassium and magnesium abnormalities. Choose an alternative antidepressant if QTc rises significantly.
Questions à poser à votre pharmacien
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Amitriptyline et Selpercatinib, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Amitriptyline
- Amitriptyline + Isocarboxazid Contre-indiquée
- Amitriptyline + Methylene blue Contre-indiquée
- Amitriptyline + Phenelzine Contre-indiquée
- Amitriptyline + Pimozide Contre-indiquée
- Amitriptyline + Procarbazine Contre-indiquée
- Amitriptyline + Safinamide Contre-indiquée
Autres interactions de Selpercatinib
- Amiodarone + Selpercatinib Majeure
- Amisulpride + Selpercatinib Majeure
- Amobarbital + Selpercatinib Majeure
- Anagrelide + Selpercatinib Majeure
- Apalutamide + Selpercatinib Majeure
- Asenapine + Selpercatinib Majeure
Questions fréquentes
Can I take Amitriptyline with Selpercatinib?
MediHelp rates the interaction as major. Amitriptyline and Selpercatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can prolong the QT interval, so combining them may increase the risk of ventricular arrhythmias including Torsades de Pointes. The risk is greater with electrolyte disturbances or underlying heart disease.
How serious is the interaction between Amitriptyline and Selpercatinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and electrolytes at baseline and periodically, correcting potassium and magnesium abnormalities. Choose an alternative antidepressant if QTc rises significantly.
What other medicines interact with Amitriptyline?
MediHelp also lists interactions of Amitriptyline with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Amitriptyline page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.